
Glimisave M 2mg/500mg Tablet PR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimisave M 2mg/500mg Tablet PR
DiaBeta-Duo 2mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiaBeta-Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, which includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to identify hypoglycemia symptoms—sweating, dizziness, headache, trembling—and know how to treat it. Maintain regular mealtimes and carry a fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart conditions should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.
Uses of Glimisave M 2mg/500mg Tablet PR
Managing type 2 diabetes
Major Benefits of Glimisave M 2mg/500mg Tablet PR:
Always follow your physician's instructions or refer to the product label for guidance. Consume Glimisave M 2mg/500mg Tablet PR with food.
Common Side effects of Glimisave M 2mg/500mg Tablet PR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimisave M 2mg/500mg Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidance. Administer Glimisave M 2mg/500mg Tablet PR with food.
How Glimisave M 2mg/500mg Tablet PR works:
Glimisave M 2mg/500mg tablets are a dual-action antidiabetic formulation combining glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts triply: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisave M 2mg/500mg Tablet PR with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimisave M 2mg/500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Postpartum use of Glimisave M 2mg/500mg tablets is contraindicated due to potential infant toxicity indicated by available data.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Glimisave M 2mg/500mg Tablet PR, potentially requiring dosage modification under medical supervision. The medication is contraindicated in those with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
The use of Glimisave M 2mg/500mg Tablet PR requires careful consideration in individuals with hepatic impairment. Dosage modification of Glimisave M 2mg/500mg Tablet PR may be necessary. Medical advice is recommended. For patients experiencing mild to moderate liver dysfunction, Glimisave M 2mg/500mg Tablet PR is typically initiated at a reduced dosage; however, it's contraindicated in those with severe liver disease.
What if you forget to take Glimisave M 2mg/500mg Tablet PR :
Should you forget a dose of Glimisave M 2mg/500mg Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimisave M 2mg/500mg Tablet PR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Treatment | Diabetes Management |
